Research and analysis

ACRE advice: application for a trial of GM Salmonella Typhi (16/R48/01)

ACRE's advice on an application to investigate the role of Salmonella Typhi bacteria in the development of typhoid fever in humans.

• From: Advisory Committee on Releases to the Environment
• Published: 22 February 2017

Documents

ACRE advice: application for a trial of GM Salmonella Typhi (16/R48/01)

PDF, 458 KB, 3 pages

Details

This document is the Advisory Committee on Releases to the Environment (ACRE’s) advice to government in considering a request from Oxford Vaccine Group (16/R48/01). The application is for a deliberate release of genetically modified Salmonella Typhi for research and development purposes.

ACRE is satisfied that the trial will not have an adverse effect on human health or the environment.

Published 22 February 2017